http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201101565-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q90-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201101565-A1
titleOfInvention METHODS OF INTRODUCTION AND COMPOSITIONS FOR THE TREATMENT OF REGIONAL FATTY TISSUE
abstract Pharmaceutical compositions, methods and systems for cosmetic alteration of body fat are proposed. The methods include administering the pharmaceutical composition of a long-acting beta-2 adrenergic receptor agonist, for example, salmeterol, which is suitable for subcutaneous administration. The methods further comprise administering a pharmaceutical composition that is suitable for subcutaneous injection comprising: (a) a lipophilic selective long-acting beta adrenergic receptor agonist and / or a glucocorticosteroid or its salt, an optical isomer, a racemate, a solvate or polymorph, and (b ) at least one subcutaneous inactive ingredient.
priorityDate 2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552739

Total number of triples: 33.